Loading field map
The design of payment systems in health care is never neutral. Every method of reimbursing providers—whether a fee for each service, a fixed monthly check per patient, or a bonus for meeting quality targets—creates a distinct set of incentives that shape clinical decisions, organizational behavior, and ultimately patient outcomes. The central tension running through this subfield is that no single payment model simultaneously optimizes cost control, quality improvement, access, and provider autonomy. Over the past seven decades, health services researchers have developed and tested six major frameworks, each responding to the limitations of its predecessors while introducing new trade-offs of its own.
From the 1950s through the 1980s, Fee-for-Service (FFS) was the dominant payment framework in most developed health systems. Under FFS, providers receive a separate payment for each identifiable service—a consultation, a test, a procedure, a hospital day. The framework’s core incentive is straightforward: more services mean more revenue. This volume-driven logic encouraged thoroughness and innovation in treatment, but it also created a powerful bias toward overuse. Providers had little reason to avoid unnecessary tests or hospitalizations, and no financial incentive to coordinate care across episodes. By the 1970s, researchers began documenting wide practice variation and rising costs that could not be explained by patient need alone. FFS, it became clear, rewarded quantity over value.
Capitation emerged in the 1970s as a direct structural alternative to FFS. Instead of paying per service, a capitation model gives providers a fixed, pre-arranged payment per enrolled patient per period, regardless of how many services the patient actually uses. The incentive flips completely: now providers profit by delivering fewer services and by keeping patients healthy enough to avoid expensive care. Capitation was adopted widely by health maintenance organizations (HMOs) and managed care plans in the United States during the 1980s and 1990s. Its strength was cost containment; its weakness was the opposite of FFS—a risk of underprovision, where providers might skimp on necessary care or avoid sicker patients. Capitation did not replace FFS entirely; instead, the two frameworks coexisted in a tense equilibrium, with FFS dominating fee-for-service sectors and capitation dominating managed care. The contrast between them defined the core debate of late-twentieth-century payment reform: volume versus fixed budgets.
By the 1990s, researchers and policymakers recognized that neither pure FFS nor pure capitation adequately addressed quality. Two new frameworks emerged to fill specific gaps. Bundled Payment (also called episode-based payment) combines all services related to a single condition or procedure—for example, a hip replacement—into one fixed price covering preoperative care, surgery, and postoperative follow-up. Unlike FFS, it discourages fragmentation and redundant services; unlike capitation, it does not reward withholding care across unrelated conditions. Bundled Payment narrows the incentive problem to a defined clinical episode, making it easier to monitor quality and cost simultaneously.
Pay-for-Performance (P4P) took a different approach. Rather than changing the base payment structure, P4P adds financial bonuses or penalties tied to specific quality measures—such as vaccination rates, readmission rates, or patient satisfaction scores. It was designed to be layered on top of existing FFS or capitation arrangements, correcting their blind spots without requiring a wholesale system redesign. Early P4P programs in the United Kingdom and the United States showed modest improvements in targeted metrics, but researchers also found unintended consequences: providers might focus only on measured activities, neglect unmeasured aspects of care, or avoid complex patients. P4P did not replace earlier frameworks; it supplemented them, introducing a quality dimension that volume-based and fixed-budget models had largely ignored.
Global Payment, which gained traction in the 2000s, extends the logic of capitation to cover all of a patient’s care—primary, specialty, hospital, and sometimes even pharmacy and long-term care—under a single, risk-adjusted budget. Unlike capitation, which often applied only to primary care or a limited set of services, Global Payment aims to give providers full accountability for a population’s total health care spending. The framework is closely tied to delivery system innovations such as accountable care organizations (ACOs) and patient-centered medical homes (PCMHs), which provide the organizational infrastructure to manage that broad financial risk. Global Payment preserves capitation’s cost-control incentive but adds a stronger emphasis on care coordination and prevention. It coexists with Bundled Payment and P4P, often within the same organization: a hospital might receive a global budget for its attributed population while also using bundled payments for specific surgical episodes and P4P bonuses for preventive care targets.
Value-Based Payment (VBP) is not simply another model in the sequence; it is a meta-framework that redefines the goal of payment reform. Emerging around 2000 and accelerating after the U.S. Affordable Care Act (2010), VBP asserts that all payment methods should be judged by their ability to improve health outcomes per dollar spent—that is, value rather than volume. Under this umbrella, earlier frameworks are not discarded but repurposed. FFS can be retained if it is linked to value metrics; capitation can be refined with risk adjustment and quality bonuses; bundled payments and P4P become tools within a larger value-oriented strategy. VBP’s distinctive commitment is to align financial incentives with patient outcomes, cost efficiency, and population health, rather than with any single payment structure. It has absorbed and transformed the earlier frameworks, turning them into components of a broader accountability system. Today, most major payment reforms in the United States and Europe are framed as value-based, even when they rely on capitation, bundled payments, or P4P mechanisms.
No single framework has won universal acceptance. Fee-for-Service remains widespread in many specialties and countries, especially for outpatient care. Capitation persists in managed care plans and some public programs. Bundled Payment is used for elective procedures and chronic disease episodes. Pay-for-Performance continues as a quality overlay. Global Payment anchors ACO models. Value-Based Payment serves as the overarching philosophy that justifies mixing and matching these approaches.
What today’s leading frameworks agree on is that payment must be linked to outcomes and that providers should bear some financial risk for the care they deliver. They disagree, however, on how much risk is appropriate, how to measure value fairly, and whether risk adjustment can adequately protect providers who care for complex patients. A persistent tension is the integration of payment reform with delivery system redesign: global budgets and bundled payments require robust data systems, care coordination infrastructure, and governance structures that many organizations lack. Researchers continue to debate whether payment incentives alone can drive improvement or whether they must be embedded in broader learning health systems that support continuous quality improvement.
The history of payment and incentives in health services is not a story of linear progress from one model to the next. It is a story of accumulating frameworks that coexist, compete, and sometimes complement each other. Understanding their relationships—how Capitation reacted to FFS, how Bundled Payment and P4P addressed specific gaps, how Global Payment expanded capitation’s scope, and how Value-Based Payment reoriented the entire enterprise—is essential for anyone who wants to design, evaluate, or reform the financial structures that shape modern health care.